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Background/Purpose: The pattern of tumor cell spread via the portal system has not 
been fully clarified in patients with hepatocellular carcinoma (HCC). This study aimed 
to evaluate the intrahepatic distribution of cancer cells derived from the main tumor by 
assessing histological portal invasion and/or intrahepatic metastasis (vp/im) .  
 
Methods: In 14 patients who underwent anatomical resection of primary solitary HCC ≤ 
50 mm in diameter, vp/im were examined	 pathologically, and the sites of the lesions 
were reproduced on preoperative 3D-CT images. The number of vp/im and the distance 
of each lesion from the tumor margin were also determined.  
 
Results: The tumor diameter was < 30 mm in seven patients (smaller HCCs) and 30-50 
mm in seven patients (larger HCCs). 3D mapping revealed that almost all vp/im were 
localized to the peritumoral area within one cm of the tumor margin in smaller HCCs, 
whereas vp/im seemed to spread extensively to the feeding 3rd level portal branches in 
larger HCCs. The number of vp/im was greater in patients with larger HCCs than in 
those with smaller HCCs.  
 
Conclusions: 3D mapping suggested tumor cells of HCC spread via the portal vein 





 Hepatic resection is a widely accepted treatment for hepatocellular carcinoma (HCC), 
but it is often difficult to determine the optimal extent of resection due to the presence 
of underlying liver disease such as chronic hepatitis or cirrhosis［1-3］. The most 
important factors related to a poor prognosis of HCC are reported to be tumor size, 
microvascular invasion of the portal vein (vp), and intrahepatic metastasis (im)［4-6］. 
In addition, it is well known that the portal vein is an efferent vessel for HCC ［7］ and 
“im” can occur by “vp” ［8-12］. Therefore, anatomical resection based on the portal 
territory is theoretically seemed to be preferable to non-anatomical resection for 
reducing postoperative intrahepatic recurrence. Although there have been several 
reports that HCC with vp and/or im (vp/im) shows early recurrence after resection［13-
19］, the pattern and extent of tumor cell spread via the portal system have not been 
fully clarified, so the optimal extent of resection is still controversial. To evaluate the 
optimum extent of resection for HCC, the distribution of microscopic vp/im was 




 Materials and Methods 
Patients 
 Institutional ethics committee approval and informed consent were obtained for this 
study. The inclusion criteria were as follows: (i) patients with primary solitary HCC, (ii) 
tumor ≤50 mm in diameter, (iii) no preoperative treatment, (iv) no preoperative portal 
vein embolization (PVE) for hypertrophy of the future liver remnant, (v) curative 
resection with an adequate margin, and (vi) a histological diagnosis of HCC. From 
January 2015 to March 2016, a total of 113 patients who underwent resection of HCC at 
our institution were considered for inclusion in this study.  Among these 113 patients, 56 
met the inclusion criteria (25 patients were excluded for recurrent tumor, seven for 
multiple tumors, eight for tumor size more than 5 cm, eight for preoperative treatment, 
six for a history of PVE and three for inadequate margins). Of these 56 patients, 26 
patients (46%) revealed a histological evidence of vp/im. Twelve of 26 patients with 
vp/im underwent non-anatomical resection. They were excluded from analysis because 
the relation between vp/im lesions and portal vein in the resected specimens could not 
be evaluated adequately. Therefore, the remaining 14 of 56 patients (25%) were 
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investigated using resected specimens (Fig. 1). Anatomical resection was defined as 
lobectomy, central bisegmentectomy, or segmentectomy, while non-anatomical 
resection was defined as resection not conforming to segmental, sectional, or lobar 
anatomy. 
 
Preparation for 3D mapping 
 In all 14 patients, fresh resected liver specimens were fixed in 10% buffered formalin, 
and serial slices about 5 mm thick were cut in the axial plane. Each slice was divided 
into several tissue blocks that were placed into Path Cassettes® labeled with the slice 
number and sequential tissue block number. All tissue blocks were further fixed in 10% 
buffered formalin, embedded in paraffin, cut into 4-µm sections, and stained with 
hematoxylin and eosin. The existence of vp/im was examined in all areas of the resected 
specimens and histological vp/im lesions were marked on the glass slides, and were 
subsequently reproduced on preoperative multi-detector CT (MD-CT) images with the 
axial plane on MD-CT images corresponding to the view of the intrahepatic vessels on 
the glass slides. Finally, 3D reconstruction of images was done using a work station 
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(SYNAPSE VINCENT®) (Fig. 2). In addition, the vp/im lesions were counted and the 
distance of each lesion measured from the border of the main tumor with a ruler to 
assess the extent of tumor spread. In this study, “im” was defined as a nodule that was 
histologically similar to or less differentiated than the main tumor［20. 21］, while 
“vp” was defined as histological portal vein tumor thrombus in the liver parenchyma. 
Because “vp” and “im” were often impossible to distinguish microscopically, both “vp” 
and “im” were investigated as portal tumor spread in this study since “im” should 
originate from “vp”. However, it was also difficult to distinguish metastasis from 
multicentric carcinogenesis in several lesions. Therefore, multicentric tumors were 




 The demographic details of the 14 studied patients are provided in table 1. All were 
classified as Child-Pugh score 5 and class A.  
Frequency of vp/im 
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 Among 56 patients with resected HCC, 26 patients (46%) showed several histological 
vp/im in this study (Fig.1). According to tumor size, 15 of 44 patients (34%) with tumors 
less than 30 mm revealed vp/im, while no less than 11 of 12 patients (91%) with tumors 30-
50 mm showed vp/im (data not shown). 
 
Number and location of vp/im 
 Table 2 showed the tumor size and histological findings in each patient. A total of 321 
sites of vp/im were found in 1528 slides prepared from the resected specimens of the 14 
patients, with vp/im being more frequent in larger HCCs than in smaller HCCs (195 vs. 
126). Among the smaller HCCs, only 1 of 126 vp/im lesions (0.7%) was located over 1 
cm from the tumor margin, while 20 of 195 lesions (10.2%) were over 1 cm from the 
margin in larger HCCs. Furthermore, four of the 195 lesions (2.0%) in larger HCCs 
were located over 2 cm from the main tumor versus no lesions in smaller HCCs (Fig. 3).  
 
3D mapping of smaller HCCs 
 Figure 4 (A, B: case 2, C-E: case 5) shows representative 3D mapping images of 
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smaller HCCs. Almost all vp/im were located within 1 cm of the tumor margin in the 
patients with smaller HCCs (Fig. 4B, D). However, case 5 had a tumor 20 mm in size of 
the confluent multinodular type macroscopically, consecutive micro-tumor thrombosis 
was detected at 11mm from the main tumor in the proximal area toward the hepatic 
hilum (Fig. 4E: black arrow).  
 
3D mapping of larger HCCs 
 Figure 5 shows 2 representative cases (A, B: case 10, C, D: case 11), in which vp/im 
seemed to spread as far as the feeding 3rd order portal venous branches of the tumor 
(Fig. 5B, D; arrow). Both of these patients had tumors over 40 mm in size. In case 11, 
HCC was infiltrative with sarcomatous change histologically, and the most distant vp/im 
in this series was detected at 4 cm from the tumor margin (Fig. 5D; circle). 
 
 Discussion 
 Hepatic resection is widely accepted as the most curative treatment for HCC, but the 
most important problem is prevention of postoperative recurrence to achieve a better 
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prognosis. It has been reported that the portal vein can act as an efferent vessel of HCC
［7］. A histological study has suggested that the main drainage vessels of 
hepatocellular nodules change from hepatic veins to hepatic sinusoids and then to portal 
veins during the multi-step process of hepatocarcinogenesis［22, 23］. In addition, it 
has been suggested that the portal vein invasion around the main tumor causes 
intrahepatic spread via the portal system and formation of secondary nodules［24］. 
With respect to preventing the spread of cancer via the portal system, complete removal 
of the portal segment containing the tumor is generally recommended to eradicate 
intrahepatic metastasis. However, it is uncertain whether anatomical resection actually 
eradicates all of the malignant cells derived from the main tumor. Therefore, we 
investigated the distribution of vp/im in resected liver specimens and also performed 
3D-CT imaging of vp/im in order to assess the spread of HCC in this study.   
 The mode of tumor cells spread is still unclear. It has been suggested that malignant 
cells spread radially in all directions from the main tumor［25］, but some authors 
have claimed that tumor cells spread via the portal territories［8-12, 26, 27］. Other 
investigators have identified malignant cells from the main tumor not only in distal 
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regions, but also proximal to the hilum which is against the direction of portal flow
［28, 29］. However, these studies assessed the peritumoral region on slides, and 3D 
investigation of tumor spread in the whole resected liver was not attempted. To our 
knowledge, this is the first report about the relation between feeding portal branches and 
the location of vp/im based on 3D images. For surgeons, it is extremely important to be 
able to predict how malignant cells spread to the surrounding liver parenchyma from the 
main HCC.  
 In the present series, vp/im were scattered extensively in the resected liver specimens of 
some patients. In particular, 3D mapping images suggested that vp/im could spread 
through the portal territories. Although we studied a limited number of patients, the 
distribution of vp/im tended to be more extensive in patients with larger HCCs than in 
those with smaller HCCs. In the patients with smaller HCCs, almost all vp/im were 
localized to the peritumoral region within 1 cm of the tumor margin, including micro 
tumor thrombosis. Furthermore, the patients with tumors 30-50 mm revealed high 
frequent vp/im compared with tumors less than 30 mm in this study. These findings 
suggested that tumor size is one of the clinical factors associated with metastasis［4-
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6］.   
 Although it remains controversial as to whether the prognosis is better with anatomical 
resection than non-anatomical resection ［1-3］, anatomical resection of a solitary 
HCC 2 to 5 cm in size was recommended to reduce postoperative recurrence according 
to the large-scale study of the Liver Cancer Study Group of Japan［2］. However, it 
was also reported that there was no significant difference of postoperative recurrence 
between anatomical and non-anatomical resection for HCCs less than 2 cm in size. 
Non-anatomical resection has recently been accepted for carefully selected tumors, and 
our results support this strategy for relatively small tumors in terms of microscopic 
tumor cell clearance.  
 In case 5, several vp/im sites were a little apart from the main tumor and micro tumor 
thrombosis was seen at the proximal side in spite of the tumor being a smaller HCC. 
This case suggested that some tumors have a high malignant potential even while small 
in size. Macroscopically, this tumor was of the confluent multinodular type. The 
macroscopic type is generally considered to be one of the risk factors for portal vein 
invasion［30-32］. Therefore, we should be aware of the tumor type before deciding 
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on the extent of resection in order to achieve curability, even if a lesion is small.  
 One of the limitations of this study is single center and small sample size. To evaluate 
the optimal extent of resection, further study with more sample size including 
postoperative prognosis will be required. Also, we could only evaluate tumor spread in 
the resected portal territory, although there is a possibility of vp/im dissemination in 
another remaining portal territory surrounding the main tumor. In order to investigate 
the tumor spread of HCC precisely, a whole liver examination using transplantation 
explants is needed.  
  
 Conclusion 
 This study showed that 3D mapping images are helpful for assessing the pattern of 
tumor spread in patients with primary solitary HCC. Our results may have implications 
for understanding the mechanism of liver tumor spreading and the treatment strategy for 
HCC. Further analysis of more patients will be required to make definitive conclusions 
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FIGURE 1. Flow chart of patients included in this study. †; lobectomy, 
central bisegmentectomy, segmentectomy, PVE; portal vein embolization, vp/im; 
microscopic portal vein invasion and/or intrahepatic metastasis   
 
FIGURE 2. Diagram shows the steps for designing 3D-mapping images. 
 
FIGURE 3. Total number and distance of vp/im lesions. Histogram shows the total 
number of vp/im lesions at each distance. “vp/im” were more frequent in larger HCCs 
than in smaller HCCs (195 vs. 126). In patients with smaller HCCs, one of 126 lesions 
(0.7%) was located over 1 cm from the tumor margin versus 20 of 195 lesions (10.2%) 
in patients with larger HCCs. Furthermore, four of 195 lesions (2.0%) were located over 
2 cm from the main tumor in patients with larger HCCs.   
 
FIGURE 4. Representative 3D mapping images of smaller HCCs (A, B: case 2, C-E: 
case 5). Dotted line shows the extent of resection in each case. The irregular 
semitransparent green region in each image shows the main tumor, while small red balls 
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indicate the sites of vp/im. Almost all the vp/im lesions were located within 1 cm of the 
tumor margin in all patients with smaller HCCs (B, D). Only 1 smaller HCC was 
associated with consecutive micro-tumor thrombosis from the main tumor in the 
proximal area toward the hilum (E; black arrow).  
 
FIGURE 5. Representative 3D mapping images of larger HCCs (A, B: case 10, C, D: 
case 11). The majority of vp/im were scattered extensively as far as the 3rd order 
branches of the portal vein (B, D; arrow). The most distant vp/im were located 4 cm 






TABLE 1. Clinicopathological data of the 14 patients 
Age 68.5 (57-81) 
Male/Female 9/5 
B/C/both negative 0/10/4 
Total bilirubin (mg/dl) 0.82 (0.28-1.53) 
Albumin (g/dl) 4.125 (3.32-4.56) 
Platelet count (103/µl) 17.0 (10.5-29.7) 
PT (%) 93.5 (59-132) 
ICG R15 (%) 15 (5-27) 
HA (ng/ml) 47 (19-207) 
AFP (ng/ml) 38.9 (1.8-7564) 
AFP L3 (%) 33.3 (1.9-75.2) 
PIVKA-  (mAU/ml) 163 (24-3611) 
Tumor size (mm) 26 (15-50) 
Extent of hepatic resection  
segmentectomy/bisegmentectomy/lobectomy 9/3/2 
Macroscopic classification    
SN/SNEG/CMN/INF 4/6/3/1 
mod/mod-poor/poor/SC 10/1/2/1 
Categorical data are expressed as the number and continuous variables are expressed as 
the median (range). B; hepatitis B virus antigen positive, C; hepatitis C virus antibody 
positive, PT; prothrombin time, ICG R15; indocyanine green retention rate at 15 
minutes, HA; hyaluronic acid, AFP; α-fetoprotein, PIVKA; protein induced by vitamin 
K absence, SN; simple nodular type, SNEG; simple nodular type with extranodular 
growth, CMN; confluent multinodular type, INF; infiltrative type, mod; moderately 
differentiated hepatocellular carcinoma, mod-poor; moderately to poorly differentiated 
hepatocellular carcinoma, poor; poorly differentiated hepatocellular carcinoma, SC; 



















1 15 SNEG mod Seg 78 < 5 
2 17 CMN mod Seg 191 < 5 
3 18 SNEG mod Seg 169 < 5 
4 20 SN poor Seg 78 < 5 
5 20 CMN mod Bi 114 11 
6 22 CMN mod Seg 39 < 5 
7 22 SN mod Bi 155 < 5 
8 30 SNEG poor Seg 154 < 5 
9 30 SN mod Seg 57 < 5 
10 40 SN mod Lob 73 22 
11 40 INF SC Bi 109 40 
12 40 SNEG mod Seg 70 17 
13 42 SNEG mod Seg 76 5 
14 50 SNEG mod-poor Lob 165 9 
*Distance of the farthest vp/im lesion from the tumor margin, SN; simple nodular type, 
SNEG; simple nodular type with extranodular growth, CMN; confluent multinodular 
type, INF; infiltrative type, mod; moderately differentiated hepatocellular carcinoma, 
mod-poor; moderately to poorly hepatocellular carcinoma, poor; poorly differentiated 
hepatocellular carcinoma, SC; hepatocellular carcinoma with sarcomatous change, Seg; 
segmentectomy, Bi; central bisegmentectomy, Lob; lobectomy 
 
 




